From Clinical Trials to Expert Perspectives: What’s New in GI Oncology
Jul 31, 2026
View online
FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer
Myriam Chalabi: A New Treatment Window for MSS Colon Cancer
CLARITY-Gastric01: Sonesitatug Vedotin Improves Overall Survival in 2L+ CLDN18.2-Positive Advanced Gastric/GEJ Cancers
LUCERNA Phase 3: Zolbetuximab, Pembrolizumab, and Chemotherapy in CLDN18.2/PD-L1–Positive Gastric/GEJ Cancer
ESMO GI 2026 Hepatobiliary Cancer Highlights: From TACE Combinations to Precision Cholangiocarcinoma Treatment
10 Must-Read Posts In GI Oncology This Week
ARISTOTLE Post-Hoc Analysis: AI-Derived Tumour Cell Density in Rectal Cancer
Exciting GI Oncology News From ESMO GI with Dr. Elisabeth Bergen
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
